Tana sells TEL 63.37: SANOFI : Regeneron and Sanofi Announce Plan to Use Priority Review Voucher For Alirocumab U.S. FDA Submission
Sanofi is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY). About Regeneron Pharmaceuticals ... Contacts Sanofi: Media Relations Investor Relations Jack Cox Sebastien Martel Tel: +33 (0) 1 53 77 94 74 Tel: +33 (0)1 53 77 45 45 Mobile: +33 ... ...
49 people liked this
0 Comments:
Post a Comment
Subscribe to Post Comments [Atom]
<< Home